Contact Us
Email Us: Customer Service
Phone (US): 703-778-3080
Fax: 703-778-3081
-
Pay Invoice
Follow Us!
Latest Blogs
- Immunoassays: A $27 Billion Market of Intrigue and Opportunity April 12, 2024
- IVD in Egypt: $440 Million Market Lead by Immunodiagnostic and Molecular Diagnostic Growth April 11, 2024
- Momentum in Multiplex Testing for IVD April 1, 2024
- Defining the Molecular Point of Care (mPOC) Market in 2024 March 14, 2024
- Cancer, Obesity, Diabetes, and Cardiovascular Disease Drive South Korea’s IVD Investment March 8, 2024
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
New Report Focuses on 23 Key Companies In Cancer Therapeutics
A new report from Kalorama Information (https://kaloramainformation.com/product/world-market-for-precision-cancer-diagnostic-tests-2022/) takes a look at cancer therapeutics, with a particular focus on 23 companies. Despite advances in cancer treatment, cancer continues to affect about 18.1 million people annually, generating a significant loss of life, financial burden and overall strain on the health industry. Worldwide between 35 and 40 million […]
The IVD Market in Singapore, Malaysia and Indonesia: 2 Billion Dollar Opportunity
Per a recent Kalorama Information report, In Vitro Diagnostics (IVD) in Malaysia, Singapore and Indonesia, 2022 (https://kaloramainformation.com/product/in-vitro-diagnostics-ivd-in-malaysia-singapore-and-indonesia-2022/). The market for IVDs in the three countries combined exceeds $1.9 billion dollars. This includes clinical tests for infectious disease, hematology, basic bloodwork, glucose and other conditions. The impact of COVID-19 in the microbiology and virology markets has […]
This Week in Cell and Gene Therapy: 13 New Developments to Know (October 12, 2022)
With the 2022 Cell & Gene Meeting on the Mesa (#CGMesa22) underway, here’s a look at some notable recent developments in cell and gene therapy featured in the bimonthly newsletter, Cell and Gene Therapy Business Outlook. Myrtelle, a clinical-stage gene therapy company based in Wakefield, MA, and Forge Biologics, a gene therapy contract development and […]
U.S. IVD Market at $54 Billion, Growth in POC Seen
Per our latest report on the United States In Vitro Diagnostics Market, the U.S. market dominates the IVD industry by region. In 2022, the U.S. occupies 42% and about $54 billion of the global market for IVD products. This major IVD market is in a state of flux, trying to manage a myriad of issues, […]
What In Vitro Diagnostic Companies Need From Contract Manufacturing Now
The contract manufacturing market is up, and it’s not just a result of excess production needs for COVID-19 trends. It’s reflective of a trend that was present even in the last decade, finds Kalorama Information’s latest report The Market for Contract Manufacturing in In Vitro Diagnostics (IVD) https://kaloramainformation.com/product/the-market-for-contract-manufacturing-in-in-vitro-diagnostics-ivd/ The contract manufacturing market for IVD products […]
The Vaccine Market Broke 200 Billion. Should Anyone Be Surprised?
In 2022, the global market for vaccines is estimated to reach $202.6 billion. COVID-19 vaccines represent roughly two thirds of these revenues, according to our just-published market research report The 2022 World Market for Vaccines (https://kaloramainformation.com/product/the-2022-world-market-for-vaccines/). Should we be surprised? Even before COVID-19, there was an increasing awareness of the role of vaccines in preventing disease. While […]
The Interplay of IVD and Vaccines
Worthy of note. We’ve published reports on in vitro diagnostics and vaccines two months a part. And the two markets are not unrelated. Testing procedure volumes will relate, usually, to the occurrence of disease. Vaccines are intended to prevent disease. (Tests perform that function as well, by suggesting isolation or treatment of patients, but vaccines […]
Decline of Microarrays as RNA Sequencing Technology Surges: Report
The total RNA sequencing market was estimated at $2,368 million ($2.37 billion) in 2021, with roughly 3/4 of revenues from consumables. The following table and graph present the estimates for 2021. This according to a new report from Kalorama Information on RNA Sequencing markets. The sequencing market has continued to provide powerful tools that hold […]
The Market for the Making of IVD Products is 15 Billion: Report
The global in vitro diagnostic (IVD) industry incorporates a sizable contract manufacturing segment that supplies a full range of reagents and test kits, instruments and systems, and testing accessories. This according to Kalorama Information’s latest report on Contract Manufacturing in IVD: https://kaloramainformation.com/product/the-market-for-contract-manufacturing-in-in-vitro-diagnostics-ivd/. The market will grow at double the rate of the overall IVD market, […]
This Week in Cell and Gene Therapy: 11 New Developments to Know (September 12, 2022)
There have been a number of recent developments in cell and gene therapy, as detailed in our bimonthly newsletter, Cell and Gene Therapy Business Outlook. Kite Pharma, a Gilead Company based in Santa Monica, CA, has announced that the European Commission (EC) has granted approval for its chimeric antigen receptor (CAR) T cell therapy Tecartus […]